https://www.selleckchem.com/products/mcc950-sodium-salt.html 5%, pylorus preserving pancreaticoduodenectomy (PpPD) 4.2%, Billroth-II gastrectomy (B-II) 11.6%, and other reconstruction method (others) 7.4%. The contributing factors calculated by a multivariate analysis were B-II (odds ratio [OR] 1.864, 95% confidence interval [CI] 1.001-3.471, p = 0.050), and the presence of naïve papilla (OR 3.268, 95% CI 1.426-7.490, p = 0.005). CONCLUSIONS DB-ERCP is a safe method with a total complication rate of 5.8% which could be considered within an acceptable range. The most common complication was the injury of the digestive tract such as perforation. Affecting risk factors for complications were B-II, and the presence of naïve papilla. DB-ERCP procedures should be performed carefully of these factors. This article is protected by copyright. All rights reserved.Experiences of cancer diagnosis are changing in light of both the increasingly technological-clinical diagnostic processes and the socio-political context in which interpersonal relations take place. This has raised questions about how we might understand patient-doctor relationship marked by asymmetries of knowledge and social capital, but that emphasise patients' empowered choices and individualised care. As part of an interview study of 155 participants with bowel or lung cancer across Denmark, England and Sweden, we explored participants' stories of the decisions made during their cancer diagnostic process. By focusing on the intersections of care, choice and medical authority - a convivial pastoral dynamic - we provide a conceptual analysis of the normative ambivalences in people's stories of their cancer diagnosis. We found that participants drew from care, choice and medical authority to emphasise their relationality and interdependence with their doctors in their stories of their diagnosis. Importantly negotiations of an asymmetrical patient-doctor relationship were part of an on-going realisation of the heal